All samples were transferred for bioanalytic assay using LCMS Data for each study are shown below: o [0253] While some embodiments have been illustrated and described, a person with ordinary skill in the art, after reading the foregoing specification, can effect changes, substitutions of equivalents and other types of alterations to the compounds of the present technology or salts, pharmaceutical compositions, derivatives, prodrugs, metabolites, tautomers or racemic mixtures thereof as set forth herein

To Elemental Calcium 500mg + Vitamin D3 Ip 250 Iu AZEVONE ACTIVE TABLET - Calcium Carbonate(600mg),vitamin D3(600 Iu),cyanocobalamin(2.2mcg) & Pyridoxine B6(2mg) Tablet AZEVONE CM TABLET - Each Fil Coated Tablet Contains Calcium Citrate Malate 250 Mg 6.25%, Vitamin D3 ( Cholecalciferol ) 100 Iu 16.66% , Folic Acid 50 Mcg 16.66 % , Excipients Q.s AZEVONE CT TABLET - Calcium Asparate 500mg, Calcium Orotate 250mg, Vitamin D3 1000 Iu, Zinc Sulphate 7.5mg, Folic Acid 1.5mg, Magnesium 50mcg & Cyanocobalamin 2.2mcg AZEVONE D3 TABLET AZEVONE FORTE K2 TABLET - Calcium Carbonate, Magnesium, Zinc Sulphate, Cyanocobalamin(methycobalamin), L- Methyfolate, Vitamin K2-7, Calcitrol AZEVONE HD TABLET - Sodium 5 Mg , Calcium Carbonate 1120 Mg (equivalent To Elemental Calcium 448 Mg) , Magnesium Oxide 180 Mg (equivalent To Elemental Magnesium 71.46 Mg), Vitamin D3 (cholecalciferol) 400 Iu AZEV ONE HEAL TABLET - Muco-polysacchatides (95%) (220 Mg) + Collagen Type 1&3 (40 Mg) + Vitamin C (20 Mg) AZEVONE JOINT TABLET AZEVONE ORO TABLET - Each Film Coated Tablet Contains : Calcium Orotate 740 Mg , Vitamin D3 Ip 1000 Iu , Magnesium Oxide 10 Mg , Excipients Q.s

This article reviews the etiology, signs, and symptoms of acetaminophen toxicity and the role of the pharmacist in the prevention of acetaminophen misuse
Lalive, P
However, for drugs such as lithium, milnacipran, pregabalin, and gabapentin that are not metabolized or little metabolized, and that are eliminated by renal excretion, 10 half-life increases in proportion to the severity of the renal disease
Tablets 8.2.3